8-K

PROCTER & GAMBLE Co (PG)

8-K 2022-04-12 For: 2022-04-12
View Original
Added on April 02, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported):  April 12, 2022


THE PROCTER & GAMBLE COMPANY

(Exact Name of Registrant as Specified in Charter)


Ohio 001-00434 31-0411980
(State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

One Procter & Gamble Plaza, Cincinnati, Ohio 45202

(Address of Principal Executive Offices, and Zip Code)

513-983-1100

Registrant’s Telephone Number, Including Area Code

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
--- ---
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
--- ---
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
--- ---

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock without Par Value PG New York Stock Exchange
2.000% Notes due 2022 PG22B New York Stock Exchange
--- --- ---
1.125% Notes due 2023 PG23A New York Stock Exchange
0.500% Notes due 2024 PG24A New York Stock Exchange
0.625% Notes due 2024 PG24B New York Stock Exchange
1.375% Notes due 2025 PG25 New York Stock Exchange
0.110% Notes due 2026 PG26D New York Stock Exchange
4.875% EUR notes due May 2027 PG27A New York Stock Exchange
1.200% Notes due 2028 PG28 New York Stock Exchange
1.250% Notes due 2029 PG29B New York Stock Exchange
1.800% Notes due 2029 PG29A New York Stock Exchange
6.250% GBP notes due January 2030 PG30 New York Stock Exchange
0.350% Notes due 2030 PG30C New York Stock Exchange
0.230% Notes due 2031 PG31A New York Stock Exchange
5.250% GBP notes due January 2033 PG33 New York Stock Exchange
1.875% Notes due 2038 PG38 New York Stock Exchange
0.900% Notes due 2041 PG41 New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934<br> (§240.12b-2 of this chapter).
--- --- ---
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting<br> standards provided pursuant to Section 13(a) of the Exchange Act.


ITEM 7.01  REGULATION FD DISCLOSURE

On April 12, 2022, The Procter & Gamble Company (the "Company") announced that its Board of Directors declared a quarterly dividend of $0.9133 per

          share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 16, 2022, to Common Stock shareholders of record at the close of business on April 22, 2022, and to
          Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on April 22, 2022.

The Company is furnishing this 8-K pursuant to Item 7.01, "Regulation FD Disclosure."

ITEM 9.01    FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits

Exhibit Number Description
99.1 Dividend News Release by The Procter & Gamble Company dated April 12, 2022.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURE<br><br> <br><br><br> <br>Pursuant to the requirements of the Securities Exchange Act of 1934, the<br> Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
---

THE PROCTER & GAMBLE COMPANY

BY:  /s/ Sandra T. Lane

Sandra T. Lane

Assistant Secretary

April 12, 2022

INDEX TO EXHIBIT(S)

Exhibit Number Description
99.1 Dividend News Release by The Procter & Gamble Company dated April 12, 2022.

News Release

The Procter & Gamble Company

One P&G Plaza

Cincinnati, OH 45202

P&G DECLARES DIVIDEND INCREASE

CINCINNATI, April 12, 2022 – The Board of Directors of The Procter & Gamble Company (NYSE:PG) declared an increased quarterly dividend of $0.9133 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 16, 2022, to Common Stock shareholders of record at the close of business on April 22, 2022, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on April 22, 2022. This represents a five percent increase compared to the prior quarterly dividend.

This dividend increase will mark the 66^th^ consecutive year that P&G has increased its dividend and the 132^nd^ consecutive year that P&G has paid a dividend since its incorporation in 1890. It reinforces our commitment to return cash to shareholders, many of whom rely on the steady, reliable income earned with their investment in P&G.

About Procter & Gamble

P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit https://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at https://www.pg.com/news.

#   #   #

P&G Media Contact

Jennifer Corso

+1-513-983-2570

P&G Investor Relations Contact

John Chevalier

+1-513-983-9974